期刊文献+

非马沙坦的合成 被引量:1

Synthesis of Fimasartan
下载PDF
导出
摘要 以2-正丁基-5-乙氧基羰基甲基-4-羟基-6-甲基嘧啶为起始原料,经水解、酰化、N-烷基化、硫代酰胺化及脱保护基等反应合成了非马沙坦,结构经MS、~1HNMR表征。对关键步骤进行了工艺改进,总收率为45%。 Fimasartan was synthesized from 2-butyl-5-ethoxycarbonylmethyl-4-hydroxy-6-methylpyrimidine by a four-step reaction of hydrolysis,acylation,N-alkylation,thioamidation and deprotection. The structure was confirmed by MS and ~1HNMR. The critical process was optimized,the overall yield was about 45%.
出处 《化学试剂》 CAS 北大核心 2016年第3期283-286,共4页 Chemical Reagents
关键词 非马沙坦 酰胺化 药物合成 fimasartan N-alkylation synthesis drugs
  • 相关文献

参考文献12

  • 1LEE J, HAN S, JEON S, et al. Pharmacokinetic-pharma- codynamics model of fimasartan applied to predict the in- fluence of a high fat diet on its blood pressure-lowering effect in healthy subjects [ J ]. Eur. J. Clin. Pharmacol. , 2013,69(1) :11-20.
  • 2PARK J B,SUNG K C,KANG S M,et al. Safety and effi- cacy of fimasartan in patients with arterial hypertension (safe-kanarb study)[ J ]. Am. J. Cardiovasc. Drug, 2013, 13(1) :47-56.
  • 3PHARM B. Pyrimidinone derivati: KR, W0/1996/008 476[ P]. 1995-09-15.
  • 4保宁制药株式会.嘧啶酮化合物及其药学上可接受的盐的制备方法:中国,0l823745.2[P].2014-04-17.
  • 5GWANG D H,KIM J H,KIM S R,et al. The preparation method for pyrimidinone compound and trihydrate of the salt of the pyrimidinone compound : KR,KR100 521 980 ( B1 ) [ P]. 2002-10-10.
  • 6KIM T W,YOO B W,LEE J K,et al. Synthesis and an- tihypertensive activity of pyrimidin-4 ( 3H ) -one deriva- tives as losartan analogue for new angiotensin II recep- tor type 1 ( AT1 ) antagonists[ J]. Bio. Org. Med. Chem. Let. ,2012,22(4):1 649-1 664.
  • 7KIM J H, LEE J H, KIM J H, et al. Fimasartan, a novel angiotensin lI receptor antagonist [ J ]. Arch. Pharm. Res. , 2012,35(7) :1 123-1 126.
  • 8CHI Yong-ha, KIM S L, TAN H K, et al. Safety, tolerabili- ty,pharmacokinetics and pharmaco dynamics of fimasar- tan following single and repeated oral administration in the fasted and fed states in healthy subjects [ J ]. Am. J. Cardiovasc. Drug, 2011,11 ( 5 ) : 335-346.
  • 9YI S, KIM J W, KIM T E, et al. Effect of multiple doses of fimasartan, an angiotensin Ill receptor antagonist, on the steady-state pharmacokinetics of digoxin in healthy volun- teers[ J ]. Int. J. Clin. Pharm. Th. , 2011,49 ( 5 ) : 321- 327.
  • 10SHIN K H,KIM T E,KIM S E,et al. The effect of the newly developed angiotensin receptor I1 antagonist fi- masartan on the pharmaeokinetics of atorvastatin in rela- tion to OATP1 B1 in healthy male volunteers[ J]. J. Card- iovasc. Pharmacol. , 2011, $8 ( 5 ) : 492-499.

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部